Bruno L. Cadilha pfp
Bruno L. Cadilha
@c-bl
First cast and thread. Why will science benefit from platforms like this one? - Coming from the field of cell therapy for hematology and oncology patients.
1 reply
0 recast
0 reaction

Bruno L. Cadilha pfp
Bruno L. Cadilha
@c-bl
On-chain proofs: shared research results can be immediately available for community review and collaborative efforts. Results are perpetuated on chain, time-stamped.
1 reply
0 recast
0 reaction

Bruno L. Cadilha pfp
Bruno L. Cadilha
@c-bl
Channels: Focused medium to remove background noise, still accessible to anyone who wants to contribute to a specific topic.
1 reply
0 recast
0 reaction

Bruno L. Cadilha pfp
Bruno L. Cadilha
@c-bl
Funding: direct transactions of funding to research labs, transparent without bs. Interested in a disease? Find active working groups, see how their projects are being developed in real time and sponsor them for the next experiment. (Unlikely to generate revenue, but) It would be possible to tokenize results.
1 reply
0 recast
0 reaction

Bruno L. Cadilha pfp
Bruno L. Cadilha
@c-bl
Dissemination: knowledge is being shared and reviewed in real time. Everything is open access by default. No publication fees or journal pay-walls for readers to access work.
1 reply
0 recast
0 reaction

Bruno L. Cadilha pfp
Bruno L. Cadilha
@c-bl
IP: ZNPs? Hash what must be preserved to secure future exploitation. But it's probably not that simple, I suppose.
1 reply
0 recast
0 reaction

Bruno L. Cadilha pfp
Bruno L. Cadilha
@c-bl
Negative results: These platforms incentivise sharing negative results - in stark contrast with traditional publishing systems. Sharing a result is one cast away and then it can be up to the community to decide if it is a dead end (or not!!!).
1 reply
0 recast
0 reaction